Novan, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 89
- Market Cap
- -
- Website
- http://www.novan.com
A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
- Conditions
- Molluscum Contagiosum
- Interventions
- Drug: SB206 10.3% berdazimerDrug: vehicle gel
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 891
- Registration Number
- NCT04535531
- Locations
- 🇺🇸
Site #334, Homestead, Florida, United States
🇺🇸Site #342, Boca Raton, Florida, United States
🇺🇸Site# 348, Fresno, California, United States
A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC
- Conditions
- Molluscum Contagiosum
- Interventions
- Drug: SB206 12%Drug: Placebo
- First Posted Date
- 2019-04-25
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 355
- Registration Number
- NCT03927703
- Locations
- 🇺🇸
Site #271, Knoxville, Tennessee, United States
🇺🇸Site #278, Miami, Florida, United States
🇺🇸Site #266, Scottsdale, Arizona, United States
A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)
- Conditions
- Molluscum Contagiosum
- Interventions
- Drug: PlaceboDrug: SB206 12%
- First Posted Date
- 2019-04-25
- Last Posted Date
- 2022-12-27
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 352
- Registration Number
- NCT03927716
- Locations
- 🇺🇸
Site #272, Rogers, Arkansas, United States
🇺🇸Site #312, Glendale, Arizona, United States
🇺🇸Site #298, Little Rock, Arkansas, United States
A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis
- Conditions
- Psoriasis
- Interventions
- Drug: SB414 6%Drug: Vehicle
- First Posted Date
- 2018-02-26
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT03445013
- Locations
- 🇺🇸
Novella Site# 247, Boise, Idaho, United States
🇺🇸Novella Site# 183, Austin, Texas, United States
🇺🇸Novella Site# 114, Norfolk, Virginia, United States
A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum
- Conditions
- Molluscum Contagiosum
- Interventions
- Drug: SB206 8%Drug: SB206 12%Drug: PlaceboDrug: SB206 4%
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 256
- Registration Number
- NCT03436615
- Locations
- 🇺🇸
Premier Site# 264, Doral, Florida, United States
🇺🇸Premier Site# 252, Norman, Oklahoma, United States
🇺🇸Premier Site# 253, Lenexa, Kansas, United States
A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: SB414 6%Drug: VehicleDrug: SB414 2%
- First Posted Date
- 2018-02-13
- Last Posted Date
- 2018-09-07
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03431610
- Locations
- 🇺🇸
Novella Site# 242, Coral Gables, Florida, United States
🇺🇸Novella Site# 264, Sweetwater, Florida, United States
🇺🇸Novella Site# 250, Portland, Oregon, United States
SB208 for the Treatment of Tinea Pedis
- Conditions
- Tinea Pedis
- Interventions
- Drug: SB208 16%Drug: Vehicle GelDrug: SB208 2%Drug: SB208 4%
- First Posted Date
- 2016-08-09
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 222
- Registration Number
- NCT02860052
- Locations
- 🇩🇴
Instituto Dermatológico y Cirugía de Piel,, Santo Domingo, Dominican Republic
Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Drug: SB204 4%
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2018-10-12
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT02801903
- Locations
- 🇺🇸
WCCT #1, Austin, Texas, United States
P3 Long Term Safety Study of Once Daily SB204 in Acne
- Conditions
- Acne Vulgaris
- Interventions
- Drug: SB204 4%
- First Posted Date
- 2016-06-14
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 601
- Registration Number
- NCT02798120
- Locations
- 🇺🇸
CIL #195, Santa Ana, California, United States
🇺🇸CIL #218, Mobile, Alabama, United States
🇺🇸CIL #210, Fresno, California, United States
P3 Study in Acne Comparing Once Daily SB204 and Vehicle
- Conditions
- Acne Vulgaris
- Interventions
- Drug: SB204 4%Drug: Vehicle Gel
- First Posted Date
- 2016-02-03
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- Novan, Inc.
- Target Recruit Count
- 1307
- Registration Number
- NCT02672332
- Locations
- 🇺🇸
CIL #146, Anaheim, California, United States
🇺🇸CIL #186, Fresno, California, United States
🇺🇸CIL #210, Fresno, California, United States